These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27574776)

  • 1. Cinobufagin enhances the protective efficacy of formalin-inactivated Salmonella typhimurium vaccine through Th1 immune response.
    Wu SC; Yi PF; Guo X; Zhang LY; Xu DX; Fu YX; Cui ZQ; Shen HQ; Wei XB; Fu BD
    Microb Pathog; 2016 Oct; 99():264-270. PubMed ID: 27574776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telocinobufagin enhances the Th1 immune response and protects against Salmonella typhimurium infection.
    Wu SC; Fu BD; Shen HQ; Yi PF; Zhang LY; Lv S; Guo X; Xia F; Wu YL; Wei XB
    Int Immunopharmacol; 2015 Apr; 25(2):353-62. PubMed ID: 25687199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone and alum synergistically augment adjuvant activities of each other in a mouse vaccine model of Salmonella typhimurium infection.
    Jazani NH; Parsania S; Sohrabpour M; Mazloomi E; Karimzad M; Shahabi S
    Immunobiology; 2011 Jun; 216(6):744-51. PubMed ID: 21093956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel adjuvant, a mixture of alum and the general opioid antagonist naloxone, elicits both humoral and cellular immune responses for heat-killed Salmonella typhimurium vaccine.
    Jazani NH; Sohrabpour M; Mazloomi E; Shahabi S
    FEMS Immunol Med Microbiol; 2011 Feb; 61(1):54-62. PubMed ID: 21054579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel adjuvant, mixture of alum and the beta-adrenergic receptor antagonist propranolol, elicits both humoral and cellular immune responses for heat-killed Salmonella typhimurium vaccine.
    Mazloomi E; Jazani NH; Shahabi S
    Vaccine; 2012 Mar; 30(16):2640-6. PubMed ID: 22342704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective Immunity Elicited by Oral Immunization of Mice with
    Erova TE; Kirtley ML; Fitts EC; Ponnusamy D; Baze WB; Andersson JA; Cong Y; Tiner BL; Sha J; Chopra AK
    Front Cell Infect Microbiol; 2016; 6():148. PubMed ID: 27891321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced immune response to a dual-promoter anti-caries DNA vaccine orally delivered by attenuated Salmonella typhimurium.
    Jiang H; Hu Y; Yang M; Liu H; Jiang G
    Immunobiology; 2017 May; 222(5):730-737. PubMed ID: 28187901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological characterization of a gidA mutant strain of Salmonella for potential use in a live-attenuated vaccine.
    Shippy DC; Fadl AA
    BMC Microbiol; 2012 Nov; 12():286. PubMed ID: 23194372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of efficacy of a new live Salmonella Typhimurium vaccine candidate in a murine model.
    Hur J; Kim MY; Lee JH
    Comp Immunol Microbiol Infect Dis; 2011 Mar; 34(2):171-7. PubMed ID: 21111480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candidate live, attenuated Salmonella enterica serotype Typhimurium vaccines with reduced fecal shedding are immunogenic and effective oral vaccines.
    Abd El Ghany M; Jansen A; Clare S; Hall L; Pickard D; Kingsley RA; Dougan G
    Infect Immun; 2007 Apr; 75(4):1835-42. PubMed ID: 17296764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel approach for the generation of Salmonella Gallinarum ghosts and evaluation of their vaccine potential using a prime-booster immunization strategy.
    Jawale CV; Lee JH
    Vaccine; 2014 Nov; 32(50):6776-82. PubMed ID: 25454861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and in vivo testing of a recombinant bovine IL-12 as an adjuvant for Salmonella typhimurium vaccination in calves.
    Takehara K; Kikuma R; Ishikawa S; Kamikawa M; Nagata T; Yokomizo Y; Nakamura M
    Vet Immunol Immunopathol; 2002 May; 86(1-2):23-30. PubMed ID: 11943327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of immune response in mice immunised with an inactivated Salmonella vaccine and gavaged with Andrographis paniculata extract or andrographolide.
    Xu Y; Chen A; Fry S; Barrow RA; Marshall RL; Mukkur TK
    Int Immunopharmacol; 2007 Apr; 7(4):515-23. PubMed ID: 17321475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-administration of live attenuated Salmonella enterica serovar Typhimurium expressing swine interleukin-18 and interferon-α provides enhanced Th1-biased protective immunity against inactivated vaccine of pseudorabies virus.
    Kim SJ; Kim SB; Han YW; Uyangaa E; Kim JH; Choi JY; Kim K; Eo SK
    Microbiol Immunol; 2012 Aug; 56(8):529-40. PubMed ID: 22551253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of protection conferred by a Salmonella Typhimurium inactivated vaccine in Salmonella-infected finishing pig farms.
    Arguello H; Carvajal A; Naharro G; Rubio P
    Comp Immunol Microbiol Infect Dis; 2013 Sep; 36(5):489-98. PubMed ID: 23743295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity induced with a Salmonella enterica serovar Enteritidis live vaccine is regulated by Th1-cell-dependent cellular and humoral effector mechanisms in susceptible BALB/c mice.
    Lehmann J; Springer S; Werner CE; Lindner T; Bellmann S; Straubinger RK; Selbitz HJ; Alber G
    Vaccine; 2006 May; 24(22):4779-93. PubMed ID: 16647169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salmonella Typhimurium, the major causative agent of foodborne illness inactivated by a phage lysis system provides effective protection against lethal challenge by induction of robust cell-mediated immune responses and activation of dendritic cells.
    Won G; Lee JH
    Vet Res; 2017 Oct; 48(1):66. PubMed ID: 29070065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
    Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
    Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
    Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
    Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salmonella Typhimurium strain expressing OprF-OprI protects mice against fatal infection by Pseudomonas aeruginosa.
    Zhang M; Sun C; Gu J; Yan X; Wang B; Cui Z; Sun X; Tong C; Feng X; Lei L; Han W
    Microbiol Immunol; 2015 Sep; 59(9):533-44. PubMed ID: 26249788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.